Cargando…

Health activation of patients in the face of a novel and unknown syndrome, Long COVID

BACKGROUND: Long COVID can still be considered as a novel disease. Although several clinical guidelines on the management of this disease have already been published, treatment options are still limited. This has left these patients frustrated in seeking treatment, and they express a willingness to...

Descripción completa

Detalles Bibliográficos
Autores principales: León-Herrera, S, Oliván Blázquez, B, Méndez-López, F, Samper-Pardo, M, Magallón-Botaya, R, Aguilar-Latorre, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595475/
http://dx.doi.org/10.1093/eurpub/ckad160.1457
_version_ 1785124876533628928
author León-Herrera, S
Oliván Blázquez, B
Méndez-López, F
Samper-Pardo, M
Magallón-Botaya, R
Aguilar-Latorre, A
author_facet León-Herrera, S
Oliván Blázquez, B
Méndez-López, F
Samper-Pardo, M
Magallón-Botaya, R
Aguilar-Latorre, A
author_sort León-Herrera, S
collection PubMed
description BACKGROUND: Long COVID can still be considered as a novel disease. Although several clinical guidelines on the management of this disease have already been published, treatment options are still limited. This has left these patients frustrated in seeking treatment, and they express a willingness to try anything to manage their symptoms. The objective of this study is to analyze the level of activation of these patients in their own health. METHODS: A cross-sectional study was performed. The sample consisted of 134 patients with Long COVID in Spain. The main variable was the activation of the patient in his own health. It was collected using the Patient Activation Measure (PAM). This tool evaluates the skills, knowledge and confidence perceived by the patient when carrying out health self-management activities. It consists of 13 items that are evaluated on a scale from 1 (totally disagree) to 4 (totally agree). The resulting score ranges from 13 to 52, and is stratified into 4 activation levels (level 1, poor activation - level 4, adequate activation). A descriptive statistical analysis was performed using the SPSS v.25 program. Frequencies and percentages were calculated for each of the ranges. RESULTS: Although there was a large percentage of participants with low levels of activation in health (28% within level 1, and 17% within level 2 activation), more than half of the study participants showed an adequate level of activation in the management and care of their own health (30% within level 3, and 23% within level 4 of activation). CONCLUSIONS: Patients with Long COVID present an adequate activation in managing their own health, which can support the actions of the professionals involved in interdisciplinary treatments for this disease. However, excessive activation and the search for any resource for symptoms management (over-the-counter medications, dietary changes, supplements) without professional control could be harmful and worsen their symptoms. KEY MESSAGES: • Patients with Long COVID present an adequate degree of activation in managing their own health. • People with Long COVID express a willingness to try anything in order to control and manage their symptoms.
format Online
Article
Text
id pubmed-10595475
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105954752023-10-25 Health activation of patients in the face of a novel and unknown syndrome, Long COVID León-Herrera, S Oliván Blázquez, B Méndez-López, F Samper-Pardo, M Magallón-Botaya, R Aguilar-Latorre, A Eur J Public Health Poster Displays BACKGROUND: Long COVID can still be considered as a novel disease. Although several clinical guidelines on the management of this disease have already been published, treatment options are still limited. This has left these patients frustrated in seeking treatment, and they express a willingness to try anything to manage their symptoms. The objective of this study is to analyze the level of activation of these patients in their own health. METHODS: A cross-sectional study was performed. The sample consisted of 134 patients with Long COVID in Spain. The main variable was the activation of the patient in his own health. It was collected using the Patient Activation Measure (PAM). This tool evaluates the skills, knowledge and confidence perceived by the patient when carrying out health self-management activities. It consists of 13 items that are evaluated on a scale from 1 (totally disagree) to 4 (totally agree). The resulting score ranges from 13 to 52, and is stratified into 4 activation levels (level 1, poor activation - level 4, adequate activation). A descriptive statistical analysis was performed using the SPSS v.25 program. Frequencies and percentages were calculated for each of the ranges. RESULTS: Although there was a large percentage of participants with low levels of activation in health (28% within level 1, and 17% within level 2 activation), more than half of the study participants showed an adequate level of activation in the management and care of their own health (30% within level 3, and 23% within level 4 of activation). CONCLUSIONS: Patients with Long COVID present an adequate activation in managing their own health, which can support the actions of the professionals involved in interdisciplinary treatments for this disease. However, excessive activation and the search for any resource for symptoms management (over-the-counter medications, dietary changes, supplements) without professional control could be harmful and worsen their symptoms. KEY MESSAGES: • Patients with Long COVID present an adequate degree of activation in managing their own health. • People with Long COVID express a willingness to try anything in order to control and manage their symptoms. Oxford University Press 2023-10-24 /pmc/articles/PMC10595475/ http://dx.doi.org/10.1093/eurpub/ckad160.1457 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Displays
León-Herrera, S
Oliván Blázquez, B
Méndez-López, F
Samper-Pardo, M
Magallón-Botaya, R
Aguilar-Latorre, A
Health activation of patients in the face of a novel and unknown syndrome, Long COVID
title Health activation of patients in the face of a novel and unknown syndrome, Long COVID
title_full Health activation of patients in the face of a novel and unknown syndrome, Long COVID
title_fullStr Health activation of patients in the face of a novel and unknown syndrome, Long COVID
title_full_unstemmed Health activation of patients in the face of a novel and unknown syndrome, Long COVID
title_short Health activation of patients in the face of a novel and unknown syndrome, Long COVID
title_sort health activation of patients in the face of a novel and unknown syndrome, long covid
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595475/
http://dx.doi.org/10.1093/eurpub/ckad160.1457
work_keys_str_mv AT leonherreras healthactivationofpatientsinthefaceofanovelandunknownsyndromelongcovid
AT olivanblazquezb healthactivationofpatientsinthefaceofanovelandunknownsyndromelongcovid
AT mendezlopezf healthactivationofpatientsinthefaceofanovelandunknownsyndromelongcovid
AT samperpardom healthactivationofpatientsinthefaceofanovelandunknownsyndromelongcovid
AT magallonbotayar healthactivationofpatientsinthefaceofanovelandunknownsyndromelongcovid
AT aguilarlatorrea healthactivationofpatientsinthefaceofanovelandunknownsyndromelongcovid